ArticleIn silico pharmacology2021

Newly designed compounds from scaffolds of known actives as inhibitors of survivin: computational analysis from the perspective of fragment-based drug design.

Olusola Olalekan Elekofehinti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.